Part Details | QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS
6505-01-123-2287
Alternate Parts: NDC00677067501, NDC00677-0675-01, QUINAGLUTE DURATAB, QUINAGLUTE DURA-TAB, NDC50419010111, NDC50419-0101-11, NDC00054874925, NDC00054-8749-25, NDC53489014101, NDC53489-0141-01, NDC53489014101, NDC53489-0141-01, NDC53489014101, NDC53489-0141-01, NDC51079002720, NDC51079-0027-20, NDC00781180413, NDC00781-1804-13, 6505-01-123-2287, 01-123-2287, 6505011232287, 011232287
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | DEC 08, 1981 | 01-123-2287 | 42586 ( QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-123-2287
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00677-0675-01 | 59225 | BAXTER HEALTHCARE CORPBAXTER AIRLIFE/PHARMASEAL DIV |
| QUINAGLUTE DURA-TAB | 59463 | BAYER HEALTHCARE PHARMACEUTICALSINC. |
| NDC50419-0101-11 | 59463 | BAYER HEALTHCARE PHARMACEUTICALSINC. |
| NDC00054-8749-25 | 34471 | BOEHRINGER INGELHEIM ROXANE, INC.DIV SUB OF BOEHRINGER INGELHEIM CORP |
| NDC53489-0141-01 | 00E55 | CARDINAL HEALTH, INC.DBA CARDINAL HEALTH |
| NDC53489-0141-01 | 0A529 | DISTRIBUTION CENTER INCUNISYS DIV |
| NDC53489-0141-01 | 0A539 | MUTUAL PHARMACEUTICAL COMPANY, INC.DBA URL PHARMA |
| NDC51079-0027-20 | 65751 | MYLAN INSTITUTIONAL INC. |
| NDC00781-1804-13 | 0THL4 | SANDOZ INC. |
Technical Data | NSN 6505-01-123-2287
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB324.000 MILLIGRAMS QUINIDINE GLUCONATE |
| PRIMARY CONTAINER TYPE | STRIP |
| FEATURES PROVIDED | INDIVIDUALLY SEALED |
| THERAPEUTIC EQUIVALENT | ANY A RATED DRUG |
| SPECIAL FEATURES | 100 TABLETS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS 324MG I.S. 100S |